Quantcast

Latest Anticoagulant Stories

2014-10-16 12:30:23

DENVER, Oct. 16, 2014 /PRNewswire/ -- Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances. The LARIAT((TM)) procedure utilizes the LARIAT((TM)) Suture Delivery Device and non-invasive techniques to access the heart and close off a region of the heart known to cause blood clots that can lead to stroke as a consequence of...

2014-10-12 23:01:29

The Firm is evaluating potential legal claims on behalf of individuals who allegedly suffered uncontrollable internal bleeding and other serious side effects due to the use of the blood thinning medication. New York, New York (PRWEB) October 12, 2014 Plaintiffs in six Xarelto lawsuits (http://www.xareltolawsuitcenter.com) have asked the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all pending and future federally-filed product liability claims involving the blood...

2014-10-06 23:02:07

The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, deep vein thrombosis, pulmonary embolism, and other serious complications, allegedly due to their use of the blood thinner. New York, NY (PRWEB) October 06, 2014 A new Xarelto lawsuit (http://www.injurybeacon.com/xarelto/lawsuit/) has been filed in Louisiana federal court on behalf of a man who allegedly suffered fatal complications due to his use of the blood thinner,...

2014-10-03 23:00:55

The Firm is evaluating potential legal claims on behalf of Xarelto patients who suffered uncontrollable internal bleeding and other complications, allegedly due to their use of the blood thinner. New York, New York (PRWEB) October 03, 2014 Xarelto lawsuits (http://www.xareltolawsuitcenter.com) alleging the blood thinner caused some patients to suffer uncontrollable internal bleeding and other life-threatening complications continue to mount in U.S courts, Bernstein Liebhard LLP reports....

2014-09-30 23:24:17

As Pradaxa Lawsuit Claims Continue Boehringer Ingelheim Conducts Clinical Trials On Idarucizumab, A Potential Reversal Agent To Pradaxa Columbus, OH (PRWEB) September 30, 2014 Wright & Schulte LLC has learned that Boehringer Ingelheim Pharmaceuticals, Inc. is testing a possible antidote for Pradaxa, the company’s oral anticoagulant that is the focus of almost 2500 Pradaxa lawsuits pending in the U.S. District Court, Southern District of Illinois alleging uncontrollable bleeding. The...

2014-09-26 08:25:09

TOKYO, Sept. 26, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it received approval from the Ministry of Health, Labour and Welfare in Japan for LIXIANA(® )(JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and...

2014-09-15 08:29:35

-Direct Oral Anticoagulant Measurement, Automated on ACL TOP® Family of Hemostasis Testing Systems- BEDFORD, Mass., Sept. 15, 2014 /PRNewswire/ --Instrumentation Laboratory (IL) today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in conjunction with HemosIL Dabigatran Calibrators and Controls, this test offers an automated solution for the measurement of dabigatran, a direct oral anticoagulant (DOAC). The assay,...

2014-09-02 23:01:40

The Firm is evaluating Xarelto lawsuits on behalf of patients who suffered uncontrollable internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death, allegedly due to their use of the blood thinner. New York, NY (PRWEB) September 02, 2014 The use of Xarelto (known generically as rivaroxaban) and other new blood thinners is growing at a rapid pace, even as Xarelto lawsuits (http://www.xareltolawsuitcenter.com) continue to mount in courts around the U.S., Bernstein...

2014-09-02 08:30:31

Patients at higher risk of kidney problems due to existing diabetes were also evaluated for the effects of warfarin on kidney function RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY® trial assessing renal function change in patients with non-valvular atrial fibrillation (NVAF) treated with Pradaxa® (dabigatran etexilate mesylate) compared to warfarin. The...

Aspirin May Reduce The Risk Of Blood Clots Reoccurring
2014-08-27 03:05:36

American Heart Association Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal Circulation. In a combined analysis of two similar independent studies, 1,224 patients who received 100 mg of aspirin a day to treat blood clots were monitored for at least two years. In the International Collaboration of Aspirin Trials for...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related